MEG3 can down-regulate Bcl-2 expression and inhibit cytochrome c release, thus leading to mitochondrial dysfunction and inducing apoptosis of RCC cells (Gong et al., 2020; Mao et al., 2021). The gene discussed is MEG3; the disease is renal cell carcinoma.